3 recruiting, 2 not yet recruiting, 1 completed. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Lenvatinib Capsules: new trials by email Literature Review of Lenvatinib Capsules trials Research Report on Lenvatinib Capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer EG-007, Pembrolizumab 100 mg/ 4 ml (25 mg/ml) Injection, Lenvatinib Capsules - Advanced Endometrial Cancer | Phase 3 | Not yet recruiting | Evergreen Therapeutics, Inc. | 450 | 2026-12-01 | 2025-12-08 |
| Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem EG-007, Pembrolizumab 100 mg/4 mL (25 mg/ml) Injection, Lenvatinib Capsules - Advanced Endometrial Cancer | Phase 2 | Not yet recruiting | Evergreen Therapeutics, Inc. | 28 | 2026-08-01 | 2025-12-08 |
| Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 Pembrolizumab, Lenvatinib Capsules - Vulva Cancer | Phase 2 | Recruiting | National Cancer Institute, Naples | 80 | 2026-03-12 | 2026-04-02 |
| Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients Lenvatinib Capsules - GIST | Phase 1 / Phase 2 | Recruiting | Asan Medical Center | 48 | 2025-10-29 | 2026-04-03 |
| Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion Olaparib tablet, Temozolomide capsule, Anlotinib - Solid Tumor, Precision Medicine | Phase 2 | Recruiting | Tianjin Medical University Second Hospital | 300 | 2024-11-01 | 2024-12-18 |
| Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy Pembrolizumab, Lenvatinib Capsules - Hepatocellular Carcinoma | Phase 2 | Completed | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 32 | 2022-05-11 | 2025-07-23 |
Carcinoma, Hepatocellular (1) · Vulvar Neoplasms (1)
Evergreen Therapeutics, Inc. (2) · Asan Medical Center (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · National Cancer Institute, Naples (1) · Tianjin Medical University Second Hospital (1)
China (1) · Germany (1) · Italy (1) · South Korea (1)
Arndt Vogel, Prof. Dr. (1) · Haitao Wang, Ph.D (1) · Salah-Eddin Al-Batran, Prof. Dr. (1) · Sandro Pignata, MD, PhD (1)
2023 (1)